Authors / Dr. Gerd Heimlich
Dr. Gerd Heimlich
Senior Sales Executive
My name is Gerd Heimlich. As Senior Executive Sales, I am responsible for the Yokogawa Life Innovation Business in Europe. My main responsibilities are sales, marketing, and development of this fast-growing business area, which includes our high content screening products, such as our CQ1 and CV8000 systems. Prior to joining Yokogawa, I spent 14 years in the scientific field and then 14 years in the medical technology industry in various business areas and functions. There I have already introduced medical products in need of explanation to the European market, sold them to various customers, and further developed innovative business areas. With our blog, we would like to keep you informed about relevant news from the life science sector at Yokogawa. We are particularly interested in the connections to current topics and our new exciting developments. In addition, contact with the respective author or specialist can be easily established via the comment function. We hope for interesting discussions that provide our readers with important new food for thought.
All articles of Dr. Gerd Heimlich
The Yokogawa Life Innovation Business recently developed in-house and through the acquisition of BioStinger Inc. new solutions for Single Cell Analysis (SCA). Today we would like to briefly introduce two new SCA research solutions.
LIFE SCIENCE GENERAL / March 17, 2021
At the end of 2019, the Yokogawa Life Innovation Business (LIB) reported on recent market strategies, product developments, and plans. Now at the beginning of the year 2021, even more great news occurred to be shared with our readers and customers in this business update article.
InSphero and their pharma and biotech partners were eager to exploit the full potential of 3D models through interrogation of specific cell population interactions and extraction of spatial and temporal information. High Content Analysis (HCA), specifically high content imaging, was recognized as a key technology to accomplish these technically challenging goals.
LIFE SCIENCE GENERAL / December 12, 2019
In order to drive the Yokogawa Life Innovation Business (LIB) forward in Europe, Dr. Gerd Heimlich joined Yokogawa as a new sales and market developer at Yokogawa Germany in 2019. He assumed responsibility for the Life Innovation Business (LIB).